{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:56:43Z","timestamp":1767135403750,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":72,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd004269.pub2","type":"reference-entry","created":{"date-parts":[[2004,10,14]],"date-time":"2004-10-14T10:08:51Z","timestamp":1097748531000},"source":"Crossref","is-referenced-by-count":37,"title":["Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation"],"prefix":"10.1002","author":[{"given":"Simon","family":"Stanworth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Heddle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Rebulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Brunskill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael F","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,10,18]]},"reference":[{"key":"10.1002\/14651858.CD004269.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1200\/JCO.1997.15.3.1143","article-title":"Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukaemia: 10 x 109\/L versus 20 x 109\/L","volume":"15","author":"Heckman","year":"1997","journal-title":"Journal of Clinical Oncology ;"},{"key":"10.1002\/14651858.CD004269.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1537-2995.1974.tb04558.x","article-title":"The prophylactic treatment of thrombocytopenic leukemic patients with platelets: a double blind study","volume":"14","author":"Higby","year":"1974","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD004269.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1046\/j.1537-2995.1999.39070674.x","article-title":"Clinical consequences of alterations in platelet dose: a prospective, randomized, double-blind trial","volume":"39","author":"Klumpp","year":"1999","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD004269.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ajh.2830120406","article-title":"Indications for platelet transfusion in children with acute leukemia","volume":"12","author":"Murphy","year":"1982","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD004269.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJM199712253372602","article-title":"The threshold for prophylactic platelet transfusions in adults with acute myeloid leukaemia","volume":"337","author":"Rebulla","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004269.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1537-2995.1973.tb05490.x","article-title":"Prophylactic platelet transfusion in children with acute leukemia: A dose response study","volume":"13","author":"Roy","year":"1973","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD004269.pub2-BIB7|cit7","first-page":"684","article-title":"Comparison of prophylactic and therapeutic single-donor platelt transfusions in patients with acute leukaemia.","volume":"50","author":"Sintnicolaas","year":"1982","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD004269.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0140-6736(78)90505-6","article-title":"Platelet prophylaxis in acute non-lymphoblastic leukemia","volume":"1 (8058)","author":"Solomon","year":"1978","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD004269.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1053\/bbmt.2002.v8.pm12434952","article-title":"A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant Recipients: 10,000\/\u00b5L versus 20,000\/\u00b5L Trigger","volume":"8","author":"Zumberg","year":"2002","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1002\/14651858.CD004269.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00000441-198603000-00001","article-title":"Bleeding due to thrombocytopenia in acute leukaemias and reevaluation of the prophylactic platelet transfusion policy","volume":"291","author":"Aderka","year":"1986","journal-title":"American Journal of the Medical Sciences"},{"key":"10.1002\/14651858.CD004269.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/tmrv.2002.29403","article-title":"Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients?","volume":"16","author":"Friedmann","year":"2002","journal-title":"Transfusion Medicine Reviews 2002"},{"key":"10.1002\/14651858.CD004269.pub2-BIB12|cit12","first-page":"931","article-title":"Clinical results of a stringent policy on prophylactic platelet transfusion: non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution","volume":"18","author":"Gil-Fernandez","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD004269.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0140-6736(91)92098-M","article-title":"Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia","volume":"338","author":"Gm\u00fcr","year":"1991","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD004269.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/10428190109057955","article-title":"Lowering the prophylactic platelet transfusion threshold: a prospective analysis","volume":"41","author":"Lawrence","year":"2001","journal-title":"Leukemia & Lymphoma"},{"key":"10.1002\/14651858.CD004269.pub2-BIB15|cit15","first-page":"998","article-title":"Prophylactic platelet transfusion threshold during therapy for adult acute meyloid leukemia: 10,000\/mL","volume":"83","author":"Navarro","year":"1998","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD004269.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1182\/blood.V92.4.1448","article-title":"Platelet transfusion: a dose response study","volume":"92","author":"Norol","year":"1998","journal-title":"Blood"},{"key":"10.1002\/14651858.CD004269.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1182\/blood.V93.9.3124","article-title":"A restrictive platlet transfusion policy allowing long term support of outpatients with severe aplastic anaemia","volume":"93","author":"Sagmeister","year":"1999","journal-title":"Blood"},{"key":"10.1002\/14651858.CD004269.pub2-BIB18|cit18","first-page":"3601","article-title":"Safety and cost effectiveness of a 10 x 109\/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 109\/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukaemia","volume":"91","author":"Wandt","year":"1998","journal-title":"Blood 1998"},{"key":"10.1002\/14651858.CD004269.pub2-BIB19|cit19","unstructured":"Clinical efficacy of platelet transfusions in relation to platelet dose given Ongoing study 1995"},{"key":"10.1002\/14651858.CD004269.pub2-BIB20|cit20","unstructured":"Trial comparing two doses of platelets Ongoing study"},{"key":"10.1002\/14651858.CD004269.pub2-BIB21|cit21","unstructured":"Pilot randomised trial comparing low and standard dose prophylactic platelet transfusions Ongoing study"},{"key":"10.1002\/14651858.CD004269.pub2-BIB22|cit22","unstructured":"Trial comparing prophylactic vs therapeutic transfusion Ongoing study"},{"key":"10.1002\/14651858.CD004269.pub2-BIB23|cit23","first-page":"141","article-title":"Comprehensive criteria for assessing therapy-induced toxicity","volume":"8","author":"Ajana","year":"1990","journal-title":"Cancer Invest"},{"issue":"12","key":"10.1002\/14651858.CD004269.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"926","DOI":"10.7326\/0003-4819-136-12-200206180-00015","article-title":"The revised Consort statement for reporting randomized trials: explanation and elaboration","volume":"136","author":"Altman","year":"2002","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD004269.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-3148.1997.d01-73.x","article-title":"A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions","volume":"7","author":"Anderson","year":"1997","journal-title":"Transfusion Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004269.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-3476(05)81705-6","article-title":"A randomized controlled trial of platelet transfusions in thrombocytopenic premature infants","volume":"123","author":"Andrew","year":"1993","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD004269.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-3148.1992.tb00175.x","article-title":"Guidelines for platelet transfusions","volume":"2","year":"1992","journal-title":"Transfusion Medicine"},{"key":"10.1002\/14651858.CD004269.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomised controlled trials: the CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004269.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood.V81.6.1411.1411","article-title":"Platelet transfusions: the 20,000\/uL trigger","volume":"81","author":"Beutler","year":"1993","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD004269.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1537-2995.1996.36496226140.x","article-title":"A prospective, randomized study of the use of platelet concentrates irradiated with ultraviolet-B light in patients with hematologic malignancy","volume":"36","author":"Blundell","year":"1996","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD004269.pub2-BIB31|cit31","first-page":"609","article-title":"Synopsis of background papers and consensus statement","volume":"101","author":"Consensus Conference on Platelet","year":"1998","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD004269.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1537-2995.1998.38898375520.x","article-title":"Final statement from the consensas conference on platelet transfusion","volume":"38","author":"Contreras","year":"1998","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD004269.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1046\/j.1537-2995.2002.00070.x","article-title":"Platelet transfusions in children: results of a randomised prospective cross-over trial of plasma removal and a prospective audit of WBC reduction","volume":"42","author":"Couban","year":"2002","journal-title":"Transfusion"},{"issue":"4","key":"10.1002\/14651858.CD004269.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1046\/j.1537-2995.2000.40040398.x","article-title":"Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study","volume":"40","author":"Wildt-Eggen","year":"2000","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD004269.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jama.1910.04330140029009","article-title":"The relation of blood platelets to hemorrhagic disease. Description of a method for determining the bleeding time and coagulation time and report of 3 cases of hemorrhagic disease relieved by transfusion","volume":"55","author":"Duke","year":"1910","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD004269.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/gyno.1995.0006","article-title":"Conservative management of chemotherapy-induced thrombocytopenia in women with gynecological cancers","volume":"59","author":"Fanning","year":"1995","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD004269.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/tmrv.2002.29403","article-title":"Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients?","volume":"16","author":"Friedmann","year":"2002","journal-title":"Transfusion Medicine Reviews"},{"key":"10.1002\/14651858.CD004269.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM196205032661802","article-title":"The quantitative relation between platelet count and hemorrhage in patients with acute leukaemia","volume":"266","author":"Gaydos","year":"1962","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004269.pub2-BIB39|cit39","first-page":"931","article-title":"Clinical results of a stringent policy on prophylactic platelet transfusion: non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution","volume":"18","author":"Gil-Fernandez","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD004269.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1200\/JCO.1997.15.3.1143","article-title":"Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukaemia: 10 x 109\/L versus 20 x 109\/L","volume":"15","author":"Heckman","year":"1997","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD004269.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1537-2995.1999.39399219278.x","article-title":"A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets","volume":"39","author":"Heddle","year":"1999","journal-title":"Transfusion"},{"issue":"5","key":"10.1002\/14651858.CD004269.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1537-2995.2002.00094.x","article-title":"A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced plateletes","volume":"42","author":"Heddle","year":"2002","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD004269.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1046\/j.1537-2995.2003.00418.x","article-title":"Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies","volume":"43","author":"Heddle","year":"2003","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD004269.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1537-2995.1998.38798346631.x","article-title":"Mathematical modeling of platelet survival with implications for optimal transfusion practice in the chronically platelet transfusion-dependent patient","volume":"38","author":"Hersh","year":"1998","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD004269.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1046\/j.1537-2995.1999.39070674.x","article-title":"Clinical consequences of alterations in platelet dose: a prospective, randomized, double-blind trial","volume":"39","author":"Klumpp","year":"1999","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD004269.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/10428190109057955","article-title":"Lowering the prophylactic platelet transfusion threshold: a prospective analysis","volume":"41","author":"Lawrence","year":"2001","journal-title":"Leukemia & Lymphoma"},{"issue":"4","key":"10.1002\/14651858.CD004269.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/1097-0142(19880815)62:4<795::AID-CNCR2820620426>3.0.CO;2-7","article-title":"A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients","volume":"62","author":"Messerschmidt","year":"1988","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD004269.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2141.1986.tb02965.x","article-title":"Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization","volume":"62","author":"Murphy","year":"1986","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD004269.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1001\/jama.1987.03390130095036","article-title":"Platelet transfusion therapy","volume":"257","year":"1987","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD004269.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1182\/blood.V92.4.1448","article-title":"Platelet transfusion: a dose response study","volume":"92","author":"Norol","year":"1998","journal-title":"Blood"},{"key":"10.1002\/14651858.CD004269.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1537-2995.1991.31791368333.x","article-title":"Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components: A randomized trial","volume":"31","author":"Oksanen","year":"1991","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD004269.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJM199712253372602","article-title":"The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia","volume":"337","author":"Rebulla","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004269.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ije\/31.1.150","article-title":"Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed","volume":"31","author":"Robinson","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD004269.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1182\/blood.V93.9.3124","article-title":"A restrictive platlet transfusion policy allowing long term support of outpatients with severe aplastic anaemia","volume":"93","author":"Sagmeister","year":"1999","journal-title":"Blood"},{"key":"10.1002\/14651858.CD004269.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood.V62.4.815.815","article-title":"A randomized trial of leukocyte-depleted platelet transfusion to modify alloimmunization in patients with leukemia","volume":"62","author":"Schiffer","year":"1983","journal-title":"Blood"},{"key":"10.1002\/14651858.CD004269.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.2001.19.5.1519","article-title":"Platelet transfusion for patients with cancer: Clinical practice guidelines of the American Society of Clinical Oncology","volume":"19","author":"Schiffer","year":"2001","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD004269.pub2-BIB57|cit57","first-page":"(Abstract 2789)","article-title":"Increasing dose improves the platelet transfusions: results of a prospective multicentre randomised study","volume":"100","author":"Sensebe","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD004269.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-0609.1992.tb00035.x","article-title":"A randomized trial comparing the use of fresh and stored platelets in the treatment of bone marrow transplant recipients","volume":"49","author":"Shanwell","year":"1992","journal-title":"European Journal of Haematology"},{"key":"10.1002\/14651858.CD004269.pub2-BIB59|cit59","first-page":"684","article-title":"Comparison of prophylactic and therapeutic single-donor platelt transfusions in patients with acute leukaemia","volume":"Abstracts","author":"Sintnicolaas","year":"1982","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD004269.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1182\/blood.V85.3.824.bloodjournal853824","article-title":"Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: A randomized prospective study","volume":"85","author":"Sintnicolaas","year":"1995","journal-title":"Blood"},{"key":"10.1002\/14651858.CD004269.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev.me.31.020180.002453","article-title":"Controversies in platelet transfusion therapy","volume":"31","author":"Slichter","year":"1980","journal-title":"Annual Reviews of Medicine"},{"key":"10.1002\/14651858.CD004269.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0889-8588(18)30517-3","article-title":"Platelet transfusion therapy","volume":"4","author":"Slichter","year":"1990","journal-title":"Hematology\/Oncology Clinics of North America"},{"issue":"4","key":"10.1002\/14651858.CD004269.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-0609.1996.tb01382.x","article-title":"Transfusion of platelet concentrates-clinical evaluation of two preprations","volume":"57","author":"Strindberg","year":"1996","journal-title":"European Journal of Haematology"},{"issue":"10","key":"10.1002\/14651858.CD004269.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1046\/j.1537-2995.2002.00203.x","article-title":"Blood Collection and transfusion in the United States in 1997","volume":"42","author":"Sullivan","year":"2002","journal-title":"Transfusion"},{"issue":"3","key":"10.1002\/14651858.CD004269.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0887-7963(03)00018-X","article-title":"Prophylactic platelet transfusions: which dose is the best dose? A review of the literature","volume":"17","author":"Tinmouth","year":"2003","journal-title":"Transfusion Medicine Reviews"},{"key":"10.1002\/14651858.CD004269.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJM199712253372601","article-title":"Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions","volume":"337","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004269.pub2-BIB67|cit67","first-page":"201","article-title":"Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: A prospective, randomized trial","volume":"77","author":"Marwijk","year":"1991","journal-title":"Blood 1991,"},{"key":"10.1002\/14651858.CD004269.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1046\/j.1537-2995.2000.40060742.x","article-title":"Summary of a workshop on in vivo efficacy of transfused platelet components and platelet substitutes","volume":"40","author":"Vostal","year":"2000","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD004269.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1182\/blood.V91.10.3601","article-title":"Safety and cost effectiveness of a 10 x 109\/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 109\/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukaemia","volume":"91","author":"Wandt","year":"1998","journal-title":"Blood"},{"key":"10.1002\/14651858.CD004269.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1634\/theoncologist.6-5-446","article-title":"New strategies for prophylactic platelet transfusion in patients with hematologic diseases","volume":"6","author":"Wandt","year":"2001","journal-title":"The Oncologist"},{"key":"10.1002\/14651858.CD004269.pub2-BIB71|cit71","first-page":"(abstract 2782)","article-title":"New strategy for platelet transfusion for patients with acute myeloid leukaemia: routine prophylactic transfusion replaced by therapeutic transfusion","volume":"100","author":"Wandt","year":"2002","journal-title":"Blood"},{"key":"10.1002\/14651858.CD004269.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1182\/blood.V83.10.3028.3028","article-title":"Bedside filtration of blood products in the prevention of HLA alloimmunization: A prospective randomized study. Alloimmunization Study Group","volume":"83","author":"Williamson","year":"1994","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004269.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,5,16]],"date-time":"2012-05-16T00:00:00Z","timestamp":1337126400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD004269.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:32:33Z","timestamp":1628530353000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004269.pub2"}},"subtitle":[],"editor":[{"given":"Michael F","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2004,10,18]]},"references-count":72,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004269.pub2","relation":{},"subject":[],"published":{"date-parts":[[2004,10,18]]}}}